NSPH Key Stats
- Nanosphere's CEO Presents at 2013 UBS Global Healthcare Services Conference (Tra... May 23
- Nanospheres High Margin Pathogen Identification System Shows Promise May 22
- New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gr... May 16
- Nanosphere to Present at UBS Global Healthcare Conference Marketwired May 15
- Morning Market Movers Benzinga May 14
- Nanosphere (NSPH) Jumps on Hitachi Deal Street Insider May 14
- Bulls pile into Take-Two Interactive May 14
- BRIEF-Nanosphere shares up 18 pct premarket May 14
- InPlay: Nanosphere announces distribution and collaboration agreement with Hitac... May 13
- Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-... May 13
NSPH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Nanosphere is up 152.1% over the last year vs S&P 500 Total Return up 27.77%, Haemonetics Corporation up 17.37%, and Harvard Bioscience up 41.32%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for NSPH
Pro Report PDF for NSPH
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download NSPH Pro Report PDF
Pro Strategies Featuring NSPH
Did Nanosphere make it into our Pro Portfolio Strategies?